{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T15:41:07Z","timestamp":1772466067723,"version":"3.50.1"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,1]]},"abstract":"<jats:title>Lay Summary<\/jats:title>\n                  <jats:p>This editorial discusses the post-hoc analysis by Dubinsky et al. evaluating upadacitinib\u2019s efficacy and safety by baseline corticosteroid use in Crohn\u2019s disease, highlighting its corticosteroid-sparing potential, the need for standardized tapering in trials, and the implications for achieving durable corticosteroid-free remission.<\/jats:p>","DOI":"10.1093\/ibd\/izaf274","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T07:27:55Z","timestamp":1763105275000},"page":"587-588","source":"Crossref","is-referenced-by-count":0,"title":["Breaking Free from Corticosteroids in Crohn\u2019s Disease"],"prefix":"10.1093","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3818-981X","authenticated-orcid":false,"given":"Raquel","family":"Oliveira","sequence":"first","affiliation":[{"name":"Gastroenterology Department, Unidade Local De Sa\u00fade Do Algarve , Portim\u00e3o,","place":["Portugal"]},{"name":"Algarve Biomedical Centre (ABC) , Faro,","place":["Portugal"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5098-8729","authenticated-orcid":false,"given":"Joana","family":"Roseira","sequence":"additional","affiliation":[{"name":"Gastroenterology Department, Unidade Local De Sa\u00fade Do Algarve , Portim\u00e3o,","place":["Portugal"]},{"name":"Algarve Biomedical Centre (ABC) , Faro,","place":["Portugal"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"key":"2026030209515945200_izaf274-B1","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/ecco-jcc\/jjaa053","article-title":"The historical role and contemporary use of corticosteroids in inflammatory bowel disease","volume":"14","author":"Dorrington","year":"2020","journal-title":"J Crohns Colitis"},{"key":"2026030209515945200_izaf274-B2","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1093\/ecco-jcc\/jjae091","article-title":"ECCO guidelines on therapeutics in Crohn\u2019s disease: medical treatment","volume":"18","author":"Gordon","year":"2024","journal-title":"J Crohns Colitis"},{"key":"2026030209515945200_izaf274-B3","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/apt.15497","article-title":"Assessment of steroid use as a key performance indicator in inflammatory bowel disease-analysis of data from 2385 UK patients","volume":"50","author":"Selinger","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"2026030209515945200_izaf274-B4","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S2468-1253(24)00034-7","article-title":"A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn\u2019s disease (PROFILE): a multicentre, open-label randomised controlled trial","volume":"9","author":"Noor","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026030209515945200_izaf274-B5","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"STRIDE-II: an update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology"},{"key":"2026030209515945200_izaf274-B6","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1093\/ibd\/izae240","article-title":"Corticosteroid use in randomized clinical trials of biologics and small molecules in inflammatory bowel disease: a systematic review","volume":"31","author":"da Silva","year":"2025","journal-title":"Inflamm Bowel Dis"},{"key":"2026030209515945200_izaf274-B7","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2025.05.015","article-title":"An international consensus on appropriate management of corticosteroids in clinical trials in inflammatory bowel disease","author":"Han\u017eel","year":"2025","journal-title":"Gastroenterology"},{"key":"2026030209515945200_izaf274-B8","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.cgh.2024.02.027","article-title":"Upadacitinib reduces Crohn\u2019s disease symptoms within the first week of induction therapy","volume":"22","author":"Colombel","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026030209515945200_izaf274-B9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41584-021-00726-8","article-title":"Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach","volume":"18","author":"Tanaka","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"2026030209515945200_izaf274-B10","article-title":"Efficacy and safety with upadacitinib by baseline corticosteroid use in patients with moderately to severely active Crohn\u2019s disease","author":"Dubinsky","journal-title":"Inflamm Bowel Dis"}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/32\/3\/587\/65287232\/izaf274.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/32\/3\/587\/65287232\/izaf274.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T14:52:04Z","timestamp":1772463124000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/32\/3\/587\/8322767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":10,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,11,13]]},"published-print":{"date-parts":[[2026,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izaf274","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2025,11,13]]}}}